Chemical activators of NaGLT1 play a pivotal role in the regulation of the protein's function, primarily through interactions at the substrate recognition sites or modulation of the cellular signaling pathways that govern its activity. Glucose, a fundamental substrate for NaGLT1, activates the protein by direct binding, which facilitates the co-transport of sodium ions alongside glucose into the cell. Similarly, Methyl-α-D-glucopyranoside, a substrate analog, engages the NaGLT1 in a manner that mirrors glucose, thus serving as a tool to measure and activate transporter function. The essential role of sodium ions in the activity of NaGLT1 is underscored by the use of Sodium chloride, which supplies sodium to enable the protein's glucose transport mechanism. Phlorizin, though classically an inhibitor, can at lower concentrations lead to an upregulation of NaGLT1 activity, suggesting a complex interaction with the transporter that goes beyond simple competitive inhibition.
Further influencing the activity of NaGLT1, Forskolin activates the protein by raising intracellular cAMP levels, which in turn activates protein kinase A (PKA). PKA can phosphorylate NaGLT1, leading to enhanced glucose transport activity. This activation route is shared by Glucagon-like peptide 1 (GLP-1), which also elevates cAMP and subsequently activates PKA, achieving a similar enhancement of NaGLT1 activity. Insulin plays a unique role by activating NaGLT1 through the PI3K/Akt signaling pathway, culminating in the increased presence of NaGLT1 on the plasma membrane and thereby elevating its functional activity. SGLT2 inhibitors like Ipragliflozin, Dapagliflozin, Canagliflozin, and Empagliflozin, primarily known for their inhibitory effects on the related SGLT2 protein, are capable of indirectly increasing NaGLT1 activity. This counterintuitive activation likely results from the body's compensatory response to inhibited glucose reabsorption elsewhere, which could lead to an upregulation of NaGLT1 function. Lastly, Pregnenolone sulfate interacts with the microenvironment of NaGLT1, which can induce changes in the protein's conformation, thereby activating its glucose transport capability.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $37.00 $194.00 $64.00 | 5 | |
Glucose activates NaGLT1 by binding to the transporter's substrate recognition sites, enabling the co-transport of sodium and glucose. | ||||||
Sodium Chloride | 7647-14-5 | sc-203274 sc-203274A sc-203274B sc-203274C | 500 g 2 kg 5 kg 10 kg | $18.00 $23.00 $35.00 $65.00 | 15 | |
Sodium chloride provides the sodium ions required for NaGLT1 to function, thereby activating the sodium-glucose co-transport mechanism. | ||||||
Phloridzin dihydrate | 7061-54-3 | sc-215708 sc-215708A | 250 mg 1 g | $48.00 $117.00 | ||
Phlorizin binds competitively to NaGLT1, initially inhibiting it, but at sub-inhibitory concentrations, it can upregulate transporter activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin elevates cAMP, which can activate protein kinase A (PKA) and phosphorylate NaGLT1, resulting in increased transporter activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin can activate NaGLT1 through the PI3K/Akt signaling pathway, leading to the translocation of NaGLT1 to the plasma membrane. | ||||||
Dapagliflozin | 461432-26-8 | sc-364481 sc-364481A sc-364481B | 5 mg 50 mg 1 g | $115.00 $420.00 $1030.00 | 6 | |
Dapagliflozin acts as a selective inhibitor, but may paradoxically activate NaGLT1 by inducing adaptive responses leading to increased activity. | ||||||
Canagliflozin | 842133-18-0 | sc-364454 sc-364454A | 5 mg 50 mg | $306.00 $408.00 | 2 | |
Canagliflozin, like other SGLT2 inhibitors, may indirectly activate NaGLT1 by triggering compensatory mechanisms in the kidney. | ||||||
Empagliflozin | 864070-44-0 | sc-482194 sc-482194A sc-482194B sc-482194C | 1 g 5 g 10 g 100 g | $156.00 $312.00 $399.00 $1099.00 | 5 | |
Empagliflozin is known to inhibit SGLT2 but could activate NaGLT1 through feedback mechanisms that compensate for reduced glucose reabsorption. | ||||||
Pregnenolone sulfate sodium salt | 1852-38-6 | sc-301609 | 50 mg | $97.00 | 2 | |
Pregnenolone sulfate activates NaGLT1 by modulating the transporter's environment, potentially affecting its conformation and activity. | ||||||